v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 29, 2025
Jun. 30, 2024
Cash Flows from Operating Activities:    
Net income $ 547,688 $ 156,224
Adjustments to reconcile net income to net cash (used)/provided by operating activities:    
Asset impairments 6,329 22,956
Depreciation and amortization 250,967 180,045
Share-based compensation expense 9,973 14,981
Equity in earnings of affiliated companies, net (4,191) (3,411)
Cash dividends from affiliated companies 5,731 5,458
Net loss/(gain) on disposition of assets 635 (957)
Net gain on divestiture of business and other assets (619,507) (4,478)
Gain on remeasurement of investment in affiliated companies 0 (6,012)
Pension and postretirement plan expense 8,731 8,843
Pension and postretirement plan contributions (10,458) (9,125)
Net decrease in deferred tax liabilities (55,633) (11,602)
Change in assets and liabilities, net of effects from acquisitions, divestitures and foreign currency adjustments:    
Trade accounts receivable (67,668) (102,497)
Inventories (203,808) 15,366
Payable to suppliers 8,056 57,929
Prepaid expenses 9,000 (51,103)
Income taxes payable and other income tax items 197,664 6,554
Accrued expenses and other assets and liabilities (98,162) (3,682)
Net cash (used)/provided by operating activities (14,653) 275,489
Cash Flows from Investing Activities:    
Purchases of property, plant and equipment (187,483) (179,694)
Cost of acquisition, net of cash acquired [1] 16,528 (3,281)
Proceeds from the sale of business, net 1,814,930 81,517
Proceeds from the sale of assets, net 1,090 333
Proceeds from settlement of net investment hedge 0 9,068
Investment in affiliated companies 0 (10,000)
Other net investing activities 242 5,448
Net cash provided/(used) by investing activities 1,645,307 (96,609)
Cash Flows from Financing Activities:    
Proceeds from issuance of debt 36,969 32,615
Principal repayment of debt (2,060,445) (112,859)
Net change in commercial paper 354,600 28,000
Net increase in book cash overdrafts 6,476 3,725
Payment of loan financing costs 0 (19,000)
Dividends paid to noncontrolling interests (243) 0
Cash dividends (103,558) (101,310)
Payments for share repurchases (10,576) (9,162)
Net cash used by financing activities (1,776,777) (177,991)
Effects of Exchange Rate Changes on Cash 32,863 (12,593)
Net Decrease in Cash and Cash Equivalents (113,260) (11,704)
Cash and cash equivalents at beginning of period 443,060 151,937
Cash and cash equivalents at end of period $ 329,800 $ 140,233
[1] During 2025, the Company received $16,528 in a final net working capital settlement related to the acquisition of Eviosys.